Trading symbol: CST
Outstanding shares: 50,261,136
OTTAWA, June 4 /CNW Telbec/ - CO2 Solution Inc. is pleased to announce
that its President and CEO, Glenn Kelly, participated in the first-ever
meeting of the newly-formed Federal BioCaucus Committee on Parliament Hill.
CO2 Solution was honored to be one of only two companies invited to present to
parliamentary Members of The BioCaucus.
"It was an excellent opportunity to present to the first-ever meeting of
the Federal BioCaucus," said Kelly. "I was able to share with Members of
Parliament information about CO2 Solution, its innovative made-in-Canada
biomimetic carbon capture technology and its immense environmental and
The BioCaucus Committee was formed to promote new economic opportunities
and benefits of biotechnology in Canada, with its Members including the Hon.
Tony Clement and St. Catharines MP Rick Dykstra.
"Biotechnology companies are emerging as engines of growth from
coast-to-coast and the founding membership of the BioCaucus is a reflection of
that. Biotechnology is the future of new jobs in clean energy, agriculture,
food sciences, and medicine," said Dykstra. "We now hope to become the focal
point for biotechnology on Parliament Hill and about how we take Canada to the
next stage of the knowledge economy."
The committee will focus on promoting the health, social and
environmental benefits of biotechnology for Canadians. It will also advocate
for the development of Canadian-based research and educational facilities to
attract new investment to become a leader in the development of new
The formation of the BioCaucus Committee, noted Kelly, is a clear
indication that the Government of Canada is forward-thinking in its approach
to economic recovery and long-term environmental sustainability.
"The introduction of the BioCaucus Committee is very encouraging," said
Kelly. "CO2 Solution looks forward to continuing to work with this committee
and the Federal Government to bring bio-technological climate change solutions
to the forefront of Canada's economy."
About CO2 Solution Inc.
Headquartered in Quebec City, CO2 Solution Inc. has developed a
proprietary bio-technological platform for the efficient capture of carbon
dioxide (CO2), the most important greenhouse gas (GHG), from power plants and
other large stationary sources of emissions.
The Company's technology platform exploits the natural power of a
biocatalyst (enzyme), carbonic anhydrase, which functions within humans and
other mammals to manage CO2 during respiration. CO2 Solution has successfully
adapted the enzyme to function within an industrial environment, and thus has
taken advantage of a biomimetic approach to CO2 capture based on millions of
years of evolution.
The Company is commercializing its technology for coal fired power
generation, the oil sands and other CO2-intensive industries where a low-cost
capture solution is key to meeting climate change legislation in a cost
CO2 Solution's technology platform is protected by several North American
and European patents, including the use of carbonic anhydrase for CO2 capture
and release in a packed column system. Additional information can be found at
For further information:
For further information: Annie Chiasson, Director, Corporate Affairs,
(418) 842-3456, firstname.lastname@example.org; www.co2solution.com